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ABSTRACT 
Background: Survival in pulmonary hypertension (PH) relates to right ventricular 
(RV) function. However, the RV unique anatomy and structure limit 2D analysis and its 
regional 3D function has not been studied yet. The aim of this study was to assess the 
implications of global and regional 3D RV deformation on clinical condition and survival in 
adults with PH and healthy controls. 
Methods and Results: We collected a prospective longitudinal cohort of 104 
consecutive PH patients and 34 healthy controls between September 2014 and December 
2015. Acquired 3D transthoracic RV echocardiographic sequences were analysed by semi-
automatic software (TomTec 4D RV-Function 2.0). Output meshes were post-processed to 
extract regional motion and deformation. Global and regional statistics provided 
deformation patterns for each subgroup of subjects.  
RV lateral and inferior regions showed the highest deformation. In PH patients, RV 
global and regional motion and deformation (both circumferential, longitudinal and area 
strain) were affected in all segments (p<0.001 against healthy controls). Deformation 
patterns gradually worsened with the clinical condition. Over 6.7 [5.8-7.2] months follow-
up, 16 (15.4%) patients died from cardio-pulmonary causes. Right atrial pressure, global RV 
area strain, TAPSE, 3D RV ejection fraction and end-diastolic volume were independent 
predictors of survival. Global RV area strain >-18% was the most powerful RV function 
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parameter, identifying patients with a 48%-increased risk of death (AUC 0.83 [0.74-0.90], 
p<0.001).  
Conclusions: RV strain patterns gradually worsen in PH patients and provide 
independent prognostic information in this population. 
KEYWORDS: pulmonary hypertension; three-dimensional echocardiography; 
speckle-tracking imaging.  
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ABBREVIATIONS 
AS   Area strain 
EDV   End-diastolic volume 
EF   Ejection fraction 
HR   Hazard ratio 
IVA   Myocardial acceleration during isovolumic contraction 
LV   Left ventricle 
PA   Pulmonary artery 
PAH   Pulmonary arterial hypertension 
PH   Pulmonary hypertension 
RV   Right ventricle 
RVOT   Right ventricular outflow tract 
SD   Standard deviation 
TAPSE   Tricuspid annular plane systolic excursion 
VTI   Velocity time integral 
WHO   World Health Organization 
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INTRODUCTION 
Pulmonary hypertension (PH) is a severe condition, responsible for symptoms and 
premature death related to right ventricular (RV) function and remodelling (1-4). In clinical 
practice, two-dimensional (2D) echocardiography is the most common RV imaging 
modality, especially in the setting of PH. Transthoracic 2D ultrasound provides a number of 
descriptors for evaluating right heart haemodynamic but is limited by the anterior position 
of the tripartite RV and the 2D one-slice plane.  
Strain estimation using speckle-tracking on 3D echocardiographic sequences has 
been suggested as a better means of assessing RV function (5,6), due to the singular 
anatomy and structure of the RV, and the inherent 3D nature of cardiac deformation. 
However, little is known about the deterioration of 3D RV function and deformation with 
disease, and their relation with survival. Descriptors of shape, sphericity (7,8) and curvature 
(9-11) have been proposed, but overall regional RV strain changes have not been studied 
yet. RV free wall peak longitudinal strain and transverse strain have previously been shown 
to relate to cardiovascular events and mortality in pulmonary hypertension (12-17), but 
finer markers and analyses are required (18,19). We hypothesized that the analysis of 
regional 3D RV strain spatiotemporal patterns, which has not been performed yet, could 
provide additional insights into the deterioration of RV function and survival. 
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To do so, we extracted both global and regional 3D RV deformation, and we adapted 
efficient computational tools to these new types of RV data. Based on these descriptors, we 
assessed whether statistical differences exist between patients with PH and healthy controls, 
and related them with clinical outcome.   
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METHODS 
Study design and patients 
We performed a prospective longitudinal study on PH patients followed up at our 
centre (Pasteur University Hospital, Nice, FR) between September 2014 and December 
2015. Consecutive clinically stable PH patients were enrolled into a standardized 
echocardiographic protocol. Healthy controls were enrolled to help determining normal 
values of 3D RV deformation imaging with our software. Our local research Ethics 
committees approved this study protocol, which conforms to the ethical guidelines of the 
1975 Declaration of Helsinki. 
Adult PH patients who consented to the study were included. Pre-capillary PH was 
considered according to right heart catheterization data, when mean pulmonary artery 
pressure at rest was ≥25 mmHg with pulmonary capillary wedge pressure ≤15 mmHg. 
Patients with significant left heart disease, arrhythmias or poor acoustic windows were 
excluded. Patients with chronic thromboembolic pulmonary hypertension were excluded if 
they had been scheduled for either endarterectomy or pulmonary angioplasty. Patients with 
PH due to lung diseases and/or hypoxemia were included only if they were considered as 
stable (regarding the respiratory status) for at least 3 months and already under oxygen if 
needed. Asymptomatic healthy volunteers were recruited from the community to serve as 
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controls and included if they had a normal trans-thoracic echocardiography, and if they 
were in sinus rhythm. 
Demographics, clinical data (age, gender, diagnosis, baseline WHO class, PH-targeted 
advanced therapy), BNP plasma levels (Beckman Access 2, Triage BNP assay (Biosite 
Diagnostics Inc, San Diego, CA)) and 6-minute walk test distance were collected at baseline. 
The time of echocardiography was considered as the start date for the study enrolment (the 
ultrasound qualifying the patient for inclusion). Follow-up was considered from the date of 
echocardiography and continued until patients either died or reached the end of the study 
(December 2015). Clinical outcome was defined by mortality related to PH. 
 
2D-echocardiographic acquisitions and measurements 
Echocardiographic examination was performed using an IE-33 or EPIQ-7 ultrasound 
system and a S5 or X5-1 transducer (Philips Medical system, Andover, MA). Doppler 
echocardiography was performed according to the recommendations of the American 
Society of Echocardiography (ASE) / European Association for Cardiovascular Imaging 
(EACVI) (20-22). 
Two different staff cardiologists, with advanced training in echocardiography, 
performed the cine-loops acquisitions and interpreted 2D-echo datasets. The measured 
parameters were averaged over three consecutive cycles. The following parameters were 
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measured: left ventricular ejection fraction, right atrial area, tricuspid annular peak systolic 
velocity (s’), myocardial acceleration during isovolumic contraction (IVA) (23), tricuspid 
annular plane systolic excursion (TAPSE), systolic pulmonary artery pressure (derived from 
the tricuspid valve regurgitation), right ventricular outflow tract (RVOT) velocity-time 
integral (VTI) and right atrial pressure estimated on the basis of IVC diameter and collapse 
(20). 
 
3D Trans-thoracic Echocardiography 
At least four 3D cine-loops of the RV were acquired from an apical 4-chamber view 
focused on the RV, using an IE-33 or EPIQ-7 ultrasound system and a matrix-array X5-1 
transducer (Philips Medical system, Andover, MA). Full-volume acquisition over 
2 heartbeats (for loop storage) was performed using ECG-gating over 4-to-6 cardiac cycles, 
during a quiet breath-hold. Frame rate was maximized to allow the use of the RV-dedicated 
quantification software. Care was taken to include the entire RV within the images. Digital 
3D data sets were stored and analysed using commercial software dedicated to the RV (4D 
RV Function 2.0, TomTec Imaging Systems GmbH, DE) (Figure 1). This software allowed 
tracking the RV endocardium along the cardiac cycle using 3D speckle-tracking. It directly 
estimated the RV end-diastolic and end-systolic volumes, ejection fraction, and wall-specific 
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peak strain. Test-retest variability (intra-operator, inter-loop and inter-operator variability) 
was also assessed in a randomly selected group of 10 patients and 10 healthy controls.  
 
Displacement and deformation analysis 
Motion and deformation were analysed at each point of the RV endocardium and at 
each instant of the cycle. Motion (3D displacement) was projected along the radial, 
circumferential and longitudinal directions. Circumferential and longitudinal strains were 
computed as the engineering strain ---the relative change of length--- along these directions, 
within a 5 mm neighborhood. Area strain was computed as the area change of each mesh 
triangle. Due to the availability of endocardial surfaces only, radial strain was not 
computed. We used the mesh correspondences provided by the commercial software to label 
the RV regions according to Haddad et al. (24) (Figure 2). 
These computations were done using VTK (v 7.10, Kitware, New York, US), and 
Matlab (v.R2011a, MathWorks, Natick, US), as previously validated in (25).  
 
Right heart catheterization  
Right heart catheterization was performed on 67 patients within 2 months from the 
ultrasound examination and in the same day on 29 patients as part of their standard 
treatment plan and follow-up.  
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Statistical analysis 
Data were summarized as mean ± standard deviation for continuous variables with 
normal distribution; median [95% confidence interval] for other continuous variables and 
number of subjects (%) for categorical variables. The variables were tested by the Student t-
test for normally distributed variables otherwise, Mann-Whitney U-test was performed. 
Categorical variables were compared using Fisher’s exact test. Bonferroni correction was 
used for multiple comparisons. Right heart catheterization data were correlated to global 
area strain using the Pearson test. The relationship between echocardiographic parameters 
and survival was assessed through univariate and multivariate Cox proportional hazard 
regression, starting at the date of echocardiography. Multivariate survival analysis included 
all variables with a p-value <0.10 in the univariate analysis as well as previously described 
prognostic parameters: WHO functional class, BNP, 6-minute walking distance and PH-
targeted advanced therapy. Receiver operating characteristics curves were constructed to 
derive the optimal cut-off values to predict survival (Youden’s index method). Test-retest 
variability consisted of intra- and inter-operator comparisons as well as inter-loop strain 
comparisons, and included intra-class correlation coefficients. For all analyses, statistical 
significance was defined as a p-value <0.05. Statistical analyses were performed using 
MedCalc 16.1 (MedCalc Software, Mariakerke, BE). 
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RESULTS 
Baseline characteristics 
One hundred four consecutive adult PH patients and 34 healthy controls were 
included in the study. One hundred seventeen patients were initially screened, 13 were 
excluded because of atrial fibrillation in 4 of them and poor acoustic window in the other 9. 
Table 1 summarizes baseline characteristics for patients and healthy controls.  
Our patients’ population included 65 (62.5%) group 1 pulmonary arterial 
hypertension (PAH) patients (detailed below), 26 (25.0%) group 3 PH patients, 11 (10.6%) 
group 4 PH patients and 2 (1.9%) group 5 PH patients according to the most recent PH 
classification (26). PAH aetiology was idiopathic PAH in 17 patients (26.2% of group 1 PAH 
patients), heritable PAH in 1 patient (1.5%), 4 drug- and toxin-induced PAH (6.2%), PAH 
associated with connective tissue disease in 16 patients (24.6%), associated with congenital 
heart disease in 13 patients (20%) (including 4 ventricular septal defects, 4 atrial septal 
defects, 1 complete atrio-ventricular septal defect and 4 closed left-to-right shunts), 
associated with portal hypertension in 12 (18.5%) patients, and HIV-associated PAH in 2 
patients (3.1%). All group 1, 4 and 5 patients as well as 9 patients from group 3 PH were 
treated with advanced targeted PAH therapy at baseline. 
Eighty-six PH patients (82.7%) had a reduced RV ejection fraction <45%, 43 of 
them (41.3%) had a TAPSE below 20 mm and 52 (50%) a BNP level above 100 ng/mL.  
Preprint version accepted to appear in European Heart Journal Cardiovascular Imaging.
Final version of this paper available at https://academic.oup.com/ehjcimaging
 15 
The full 3D RV analysis using TomTec software required an average of 
185±42 seconds including image alignment and manual correction of the detected 
endocardial RV borders. 
 
RV segmental and global strain  
 Global and regional RV strain comparisons between patients and healthy controls are 
summarized in Tables 1 and 2. In healthy controls, area strain predominated at the lateral 
and inferior wall. Circumferential and longitudinal RV strain predominated at the lateral 
and inferior wall, respectively. The septal component of the RV also contributed to the 
global RV deformation. As compared to healthy controls, PH patients had significantly 
reduced global and regional RV area strain (in all RV segments, p<0.001). Similar 
observations were made for the RV longitudinal and circumferential strain in all segments.  
 
Link with the severity of the disease 
 A gradient in RV area strain was observed according to the severity of the disease 
(assessed by baseline WHO functional class, Figure 3 and 4). It was accompanied by a 
gradual dilatation of the RV (Table 3). Apart from this gradual decrease in the peak 
deformation, a slight but gradual delay in the contraction was also associated with the WHO 
class, as visible in all the strain components at the segments with higher contraction (RV 
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lateral, Figure 5). We tested the correlation between global RV area strain and invasive 
parameters collected the same day in a subset of 29 patients. None of the invasive 
parameters were significantly associated with global RV area strain: pulmonary vascular 
resistance (r=0.10; p=0.4); mean pulmonary artery pressure (r=0.20; p=0.3); cardiac 
index (r=-0.16; p=0.4); right atrial pressure (r=-0.12; p=0.6). On the opposite, RV 
ejection fraction was closely associated to RV global area strain (r=-0.90, p<0.0001). 
 
Survival analysis 
 Over a median follow-up of 6.7 months [5.8–7.2], 16 patients (15.4%) died from 
cardio-pulmonary causes. On univariate survival analysis, baseline WHO functional class IV 
(HR 2.89 [1.08-7.72]; p=0.03), 6-minute walking distance (HR 0.98 [0.97-1.00]; p=0.05), 
PH-targeted advanced therapy (HR 0.24 [0.09-0.67]; p=0.006), BNP (HR 1.002 [1.001-
1.003]; p<0.001), invasive mean PA pressure (HR 1.06 [1.01-1.11]; p=0.02) were 
predictors of survival. Echocardiographic predictors of survival on univariate analysis 
included 3D RV ejection fraction (HR 0.87 [0.81-0.93]; p<0.001), 3D RV end-diastolic 
volume (HR 1.02 [1.01-1.03]; p<0.001), moderate or severe tricuspid regurgitation (HR 
8.45 [3.08-23.15]; p<0.001), systolic PA pressure (HR 1.03 [1.01–1.05]; p=0.009), right 
atrial pressure (HR 1.41[1.24-1.61]; p<0.001), right atrial area (HR 1.08 [1.05-1.12]; 
p<0.001), pulmonary VTI (HR 0.86 [0.75-0.98]; p=0.02), tricuspid s’ (HR 0.82 [0.69-
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0.97]; p=0.02), TAPSE (HR 0.8 [0.72-0.90]; p<0.001), global RV area strain (HR 1.34 
[1.18-1.52]; p<0.001), global RV circumferential strain (HR 1.53 [1.24-1.88]; p<0.001) 
and global RV longitudinal strain (HR 1.31 [1.10-1.56]; p=0.002). 
 On multivariate analysis including baseline WHO functional class, BNP, 6-minute 
walking distance and PH-targeted advanced therapy as covariates, global area strain (HR 
1.72 [1.07-2.78]; p=0.03), 3D RV ejection fraction (HR 0.80 [0.64-0.99], 3D RV end-
diastolic volume (HR 1.03 [1.00-1.05]; p=0.02), TAPSE (HR 0.72 [0.52-0.99]; p=0.04) and 
right atrial pressure (HR 1.61 [1.09-2.36]; p=0.02) were independent predictors of survival.  
On receiver operating curve analysis, the average area under the curve for the global 
RV area strain was 0.83 [0.74-0.90], p<0.001 compared to 0.81 [0.72-0.88], p<0.001 for 
TAPSE and 0.80 [0.71-0.87], p<0.001 for 3D RV ejection fraction (Figure 6). Global RV 
area strain >-18% identified patients at high risk of mortality with a sensitivity of 94% and 
a specificity of 62%.  
  
Reproducibility 
Intra-class correlation coefficients for inter-observer variability were 0.90 [0.77-0.96] for RV 
EF and 0.94 [0.86-0.98] for RV EDV. Intra-class correlation coefficients for intra-observer 
variability (same cine loop analysed) were 0.95 [0.88-0.98] for RV EF, 0.98 [0.96-0.99] for 
RV EDV and 0.93 [0.83-0.97] for RV global area strain, respectively. Intra-class correlation 
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coefficients for inter-loop variability (intra-observer variability using a second dataset 
acquired at a different time) were 0.94 [0.86-0.98] for RV EF, 0.94 [0.86-0.98] for RV EDV 
and 0.94 [0.86-0.98] for RV global area strain.   
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DISCUSSION 
Studying the RV function is challenging but of critical importance, especially in a 
devastating disease such as pulmonary hypertension. Our study analysed for the first time 
RV 3D deformation patterns in healthy controls and pulmonary hypertension patients using 
dedicated RV software. Our results highlight the role of regional deformation analysis, 
which reveal the dominant RV regions (inferior and lateral wall) and subtle pattern changes 
with disease severity. This study also demonstrates the prognostic role of RV area strain in 
PH patients. 
 
2D vs 3D RV analysis and regional function 
Standard evaluation of the RV usually requires 2D assessment (20). Despite being 
correlated with MRI RV EF, widely used parameters such as TAPSE and TV s’ (to assess RV 
function in routine clinical practice) only assess the lateral tricuspid annulus. 2D speckle-
tracking echocardiography has been used to quantify RV myocardial deformation, but 
mainly focuses on longitudinal strain. Indeed, given the complex anatomy of the RV, 
circumferential strain cannot be fully assessed by 2D techniques. Actually, MRI studies have 
highlighted the value of considering RV circumferential strain for some pathologies such as 
arrhythmogenic RV cardiomyopathy (27) or RV afterload changes (28,29). Besides, going 
beyond global measurements and assessing regional RV function is determinant in the 
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evaluation of Tetralogy of Fallot patients (30-32) and pulmonary embolism (33,34), but is 
usually assessed with MRI. In this study, we demonstrate using dedicated software the 
feasibility and high value of 3D echocardiographic analysis to estimate RV ejection fraction, 
volumes (35), and regional RV function (36) in healthy volunteers and PH patients. We also 
believe that adding circumferential strain to the longitudinal RV strain analysis, which 
allows computing RV area strain, provides additional prognostic information.  
The tracking accuracy and therefore the relevance of motion and deformation values 
were fully conditioned by the Tomtec commercial software, whose use has been validated in 
(37). Our post-processing software only uses standard mathematical formulations to 
compute local motion and deformation from already existing mesh data, and corresponds to 
the validated tools (25).  
Our study provides a new statistical characterization of 3D RV deformation patterns. 
It first illustrates the normal contraction pattern over the whole RV: the lateral wall is 
predominant in terms of area strain, but the inferior wall, the anterior wall as well as the 
inlet septum are also significant contributors to the RV global area change. Longitudinal 
deformation predominates at the inferior wall, whereas the lateral wall provides more 
circumferential deformation. Then, this statistical characterization is extended to the 
comparison of PH against healthy deformation patterns, and confirms that RV dysfunction 
predominates in these regions.  
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RV remodelling and outcome 
 Our method provided a reliable full analysis of the right ventricle, including regional 
analysis. Using left ventricle-dedicated software, previous studies already reported that RV 
global area strain is associated with outcomes in PH (16,38,39). Our results confirm the 
prognostic role of RV area strain. The use of dedicated RV software allowed studying the 
entire RV structure and refining observations at the regional level. Despite playing a 
“minor” role as compared to the lateral, anterior and inferior wall, the RVOT and 
infundibular septum significantly contribute to RV area strain. This opens the door to 
complementary analyses of the RV function in PAH, such as the timing alteration of RV 
segments. 
RV adverse remodelling, RV dilatation and reduction in RVEF and/or area strain are 
associated with mortality in our cohort of PH patients. Cardiac index, a known but debated 
invasive indicator of prognosis reflecting RV contractility (40), did not reach statistical 
significance in our cohort, probably because of the low number of patients with right heart 
catheterization data. RV area strain is independently and strongly associated with survival, 
illustrating the initial role of decreasing strain before reducing RV EF and dilating the 
cavity. Indeed, our echocardiographic parameter could be interpreted as a consequence of 
the RV-PA unit, a marker of RV-PA coupling (41), which among other parameters has been 
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recently related to prognosis in PH (42). Finer markers of RV function like area strain are 
therefore useful to detect early changes in PAH patients and could help improving the 
follow-up and prognosis of such patients. 
 
Limitations 
 3D RV analysis was feasible in 88.9% of patients, the main limitation being the 
imaging quality. Given the expected intra-individual variability, patients with atrial 
fibrillation were excluded from this preliminary study. This could represent a selection bias. 
Patients with post-capillary PH were not studied and the conclusions made in this paper are 
consequently not extendable to this population. Indeed, left heart disease could influence RV 
deformation.  
Classically, 3D RV assessment was limited by its feasibility. In our study, thanks to 
RV dedicated software, intra- and inter-operator and inter-loop reproducibility were 
acceptable, as previously described (37). Furthermore, the duration of the 3D quantification 
analysis was acceptable and could be applicable in routine clinical practice. 
Our cohort of control patients was relatively small, as compared to the PH group. 
Indeed, identifying patients in the Echo Lab, without any structural heart disease 
(potentially influencing RV remodelling) has been very difficult. Furthermore, this issue 
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prevents us from age-matching our control population to the PH population. Indeed, this 
could represent another limitation given that age could influence 3D RV quantification (43). 
The lack of correlation between haemodynamic parameters and RV area strain can 
be confusing. However, this could be expected, as the number of patients with invasive data 
was relatively low compared to the overall number of patients. Right atrial pressure, a 
strong marker of risk in PH patients was also a predictor of mortality in our population, but 
not related to RV area strain. This might be explained by the evolution of PH itself as right 
atrial pressure increases gradually with RV dysfunction, while RV area strain might be an 
earlier marker of RV dysfunction, explaining the relative independence of both markers. 
The prognostic importance of decreased RV area strain is obvious in our cohort, however as 
our patients suffer from multiple PH aetiologies, a larger multicentre study could help 
verifying and generalizing our conclusions in a larger population. Given the relatively small 
cohort of patients, no etiological subgroup analysis was performed. A larger study would 
allow describing RV shape and deformation patterns in a finer way for each PH aetiology, 
especially in group 1 patients.  
Preprint version accepted to appear in European Heart Journal Cardiovascular Imaging.
Final version of this paper available at https://academic.oup.com/ehjcimaging
 24 
CONCLUSIONS 
We examined the implications of a finer analysis of 3D RV deformation on clinical 
condition and survival in a cohort of adults with PH and 34 healthy controls. We 
quantitatively demonstrated that RV strain patterns gradually worsen in PH patients and 
provide independent prognostic information. This new technique could help better 
stratifying the risk in PH patients. 
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FIGURE LEGENDS 
 
Figure 1: Example of RV 3D analysis using TomTec 4D RV function 4.0 
A. Initial alignment of 3D dataset and identification of landmarks. 
B. End-systolic verification and editing of endocardial RV borders. 
 
Figure 2: RV regions used in our study, according to Haddad et al. (24) 
 
Figure 3: End-systolic strain patterns according to baseline WHO class: the median pattern 
over each WHO subgroup is represented on the subgroup average shape. 
 
Figure 4: End-systolic global area strain according to baseline WHO class. 
 
Figure 5: Motion and deformation along the cycle according to the functional capacity 
(median and first/third quartiles over each subgroup, at the RV lateral segment). 
 
Figure 6: Kaplan-Meier and ROC curves for prediction of survival.  
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TABLES 
 
Table 1: Baseline characteristics of the population, including three-dimensional and RV 
deformation data. 
 Pulmonary 
hypertension 
n=104 
Healthy controls 
n=34 
p-value 
Age, y 65.9 [62.0-68.8] 45.5 [33.7-50.4] <0.001 
Female sex, n (%) 58 (55.8%) 15 (44.1%) 0.3 
Body surface area, m2 1.72±0.2 1.75±0.1 0.3 
WHO functional class  III 66 (63.4%)   
BNP, ng/mL 126 [94.0-182.0]   
6MWD, m 359.5±106   
AT at baseline, n (%) 87 (83.7%)   
Death, n (%) 16 (15.4%)   
2D Echocardiographic data    
    LVEF, % 69.1±8.5   
    Right atrial pressure, mmHg 10.0 [10.0-10.0]   
    Right atrial surface, cm2 24.0 [22.4-25.0]   
    Pulmonary VTI, cm 15.0±4.7   
    Systolic PAP, mmHg 75.2±24.9   
    TAPSE, mm 20.4±5.2   
    Tricuspid s’, cm/s 11.6±3.0   
    IVA, m/s2 2.0 [1.9-2.2]   
RHC data    
    PVR, Wood U 6.6[5.9-7.6]   
    Mean PAP, mmHg 43.3±12.6  
Min-max [25-70] 
  
    Right atrial pressure, mmHg 9.0 [7.0-10.0]   
    Cardiac index, L/mn/m2 2.7 [2.4-2.8]   
3D Echocardiographic data    
    RV EF, % 35.6±9.7 55.9±5.8 <0.001 
    RV EDV, mL 91.0±40.6 51.4±21.9 <0.001 
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    Global Area strain, % -18.8±5.4 -29.5±4.4 <0.001 
    Global Circumferential strain, % -11.6±3.6 -17.3±3.2 <0.001 
    Global Longitudinal strain, % -8.4±3.6 -14.1±3.6 <0.001 
    Frame rate, Hz 17.7 [16.6-18.7] 18.0 [17-19] 0.1 
6MWD, 6-minute walk test distance; AT, advanced therapy; BNP, brain natriuretic peptide; 
EDV, end-diastolic volume; EF, ejection fraction; IVA, myocardial acceleration during 
isovolumic contraction; LVEF, left ventricular ejection fraction; PAP, pulmonary artery 
pressure; PVR, pulmonary vascular resistance; RHC, right heart catheterization; RV, right 
ventricular; TAPSE, tricuspid annular plane systolic excursion; VTI, velocity-time integral.  
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Table 2: RV regional deformation data in healthy and PH subjects.  
 
 Pulmonary 
hypertension 
n=104 
Healthy 
Controls 
n=34 
p value 
Area strain, %    
     Anterior wall -17.8±7.0 -29.5±6.6 <0.001 
     Inferior wall -24.4±8.8 -37.9±7.4 <0.001 
     Lateral wall -28.5±9.1 -43.4±6.6 <0.001 
     RVOT anterior -14.7±6.0 -22.2±5.9 <0.001 
     Infundibular septum -17.8±7.0 -27.2±7.1 <0.001 
     Membranous septum -14.7±7.6 -23.3±8.1 <0.001 
     Inlet septum -16.7±8.2 -27.8±9.4 <0.001 
     Trabeculated septum -15.9±6.3 -24.8±7.1 <0.001 
Circumferential strain, %    
     Anterior wall -12.9±6.2 -20.8±7.4 <0.001 
     Inferior wall -13.4±6.3 -20.4±6.0 <0.001 
     Lateral wall -19.0±6.2 -29.5±6.2 <0.001 
     RVOT anterior -7.8±3.7 -11.6±4.6 <0.001 
     Infundibular septum -12.1±3.8 -16.7±3.9 <0.001 
     Membranous septum -8.4±4.0 -11.7±3.5 <0.001 
     Inlet septum -10.3±6.1 -14.6±6.5 0.001 
     Trabeculated septum -8.7±4.4 -13.1±4.7 <0.001 
Longitudinal strain, %    
     Anterior wall -6.5±3.6 -10.8±4.3 <0.001 
     Inferior wall -12.2±4.9 -20.3±5.8 <0.001 
     Lateral wall -10.5±4.6 -16.0±3.8 <0.001 
     RVOT anterior -8.3±5.1 -12.5±5.9 <0.001 
     Infundibular septum -7.1±6.1 -11.2±5.8 0.001 
     Membranous septum -7.3±6.0 -13.2±6.7 <0.001 
     Inlet septum -7.4±5.6 -14.9±7.3 <0.001 
     Trabeculated septum -7.8±3.8 -13.4±5.0 <0.001 
 
RV, right ventricular; RVOT, right ventricular outflow tract.  
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Table 3: Three-dimensional and RV deformation data according to baseline WHO functional 
class in PH patients. 
 
WHO II 
n=38 
WHO III 
n=46 
WHO IV 
n=20 
p-value 
II vs III 
p-value 
II vs IV 
p-value 
III vs IV 
RV EF, % 38.9±8.7 35.5±8.8 29.4±10.9 0.27 <0.001 0.04 
RV EDV, mL 78.1±29.6 90.6±43.0 116.6±42.7 0.43 0.001 0.04 
Global Area strain, % -20.4±5.4 -18.9±4.4 -15.6±6.1 0.61 0.003 0.05 
Global Circumferential strain, % -12.5±3.4 -11.5±3.2 -10.0±4.3 0.5 0.04 0.4 
Global Longitudinal strain, % -9.3±3.9 -8.6±3.0 -6.3±3.3 0.99 0.007 0.05 
EDV, end-diastolic volume; EF, ejection fraction; PH, pulmonary hypertension; RV, right 
ventricular. 
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